This article has been updated with comments from Wells Fargo and corrected to acurately reflect the expected Q4 and FY 2015 EPS figures.

NEW YORK (GenomeWeb) – Qiagen today reported preliminary earnings for the fourth quarter and Fiscal Year 2015 that fell short of management's outlook and analyst expectations. The firm also reported a previously undisclosed acquisition of sample prep firm Mo Bio Laboratories.